
Bausch + Lomb (BLCO) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.3B
Gross Profit
753.0M
58.92%
Operating Income
11.0M
0.86%
Net Income
-58.0M
-4.54%
EPS (Diluted)
$-0.18
Balance Sheet Metrics
Total Assets
13.4B
Total Liabilities
7.0B
Shareholders Equity
6.4B
Debt to Equity
1.09
Cash Flow Metrics
Operating Cash Flow
-32.0M
Free Cash Flow
-135.0M
Revenue & Profitability Trend
Bausch + Lomb Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.8B | 4.1B | 3.8B | 3.8B | 3.4B |
Cost of Goods Sold | 1.9B | 1.6B | 1.5B | 1.5B | 1.3B |
Gross Profit | 2.9B | 2.5B | 2.2B | 2.3B | 2.1B |
Gross Margin % | 60.9% | 60.4% | 59.7% | 61.0% | 62.3% |
Operating Expenses | |||||
Research & Development | 343.0M | 324.0M | 308.0M | 276.0M | 281.0M |
Selling, General & Administrative | 2.1B | 1.7B | 1.5B | 1.4B | 1.3B |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 2.4B | 2.1B | 1.8B | 1.7B | 1.5B |
Operating Income | 206.0M | 204.0M | 219.0M | 341.0M | 270.0M |
Operating Margin % | 4.3% | 4.9% | 5.8% | 9.1% | 7.9% |
Non-Operating Items | |||||
Interest Income | 15.0M | 15.0M | 6.0M | 0 | 3.0M |
Interest Expense | 399.0M | 283.0M | 146.0M | 0 | 0 |
Other Non-Operating Income | -56.0M | -102.0M | -6.0M | -23.0M | 17.0M |
Pre-tax Income | -234.0M | -166.0M | 73.0M | 318.0M | 290.0M |
Income Tax | 71.0M | 82.0M | 58.0M | 125.0M | 307.0M |
Effective Tax Rate % | 0.0% | 0.0% | 79.5% | 39.3% | 105.9% |
Net Income | -305.0M | -248.0M | 15.0M | 193.0M | -17.0M |
Net Margin % | -6.4% | -6.0% | 0.4% | 5.1% | -0.5% |
Key Metrics | |||||
EBITDA | 657.0M | 601.0M | 604.0M | 757.0M | 714.0M |
EPS (Basic) | $-0.90 | $-0.74 | $0.02 | $0.52 | $-0.05 |
EPS (Diluted) | $-0.90 | $-0.74 | $0.02 | $0.52 | $-0.05 |
Basic Shares Outstanding | 351800000 | 350500000 | 350000000 | 350000000 | 350000000 |
Diluted Shares Outstanding | 351800000 | 350500000 | 350000000 | 350000000 | 350000000 |
Income Statement Trend
Bausch + Lomb Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 305.0M | 331.0M | 354.0M | 174.0M | 238.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 1.0B | 839.0M | 724.0M | 721.0M | 645.0M |
Inventory | 1.0B | 1.0B | 628.0M | 572.0M | 616.0M |
Other Current Assets | 410.0M | 541.0M | 405.0M | 165.0M | 155.0M |
Total Current Assets | 2.8B | 2.7B | 2.1B | 1.6B | 1.7B |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 335.0M | 232.0M | 204.0M |
Goodwill | 12.5B | 12.7B | 11.1B | 11.4B | 11.9B |
Intangible Assets | 3.5B | 3.6B | 2.1B | 2.3B | 2.6B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 1.2B | 1.1B | 1.1B | 1.1B | 1.2B |
Total Non-Current Assets | 10.7B | 10.7B | 9.0B | 9.2B | 9.6B |
Total Assets | 13.5B | 13.4B | 11.1B | 10.8B | 11.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 389.0M | 522.0M | 370.0M | 239.0M | 178.0M |
Short-term Debt | 40.0M | 30.0M | 25.0M | 28.0M | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 403.0M | 400.0M | 342.0M | 316.0M | 278.0M |
Total Current Liabilities | 1.7B | 1.6B | 1.3B | 1.1B | 909.0M |
Non-Current Liabilities | |||||
Long-term Debt | 4.7B | 4.5B | 2.4B | - | - |
Deferred Tax Liabilities | 13.0M | 14.0M | 7.0M | 24.0M | 27.0M |
Other Non-Current Liabilities | 430.0M | 397.0M | 329.0M | 298.0M | 342.0M |
Total Non-Current Liabilities | 5.2B | 4.9B | 2.7B | 322.0M | 369.0M |
Total Liabilities | 6.9B | 6.5B | 4.0B | 1.4B | 1.3B |
Equity | |||||
Common Stock | 0 | 0 | 0 | 0 | 10.8B |
Retained Earnings | -571.0M | -254.0M | 6.0M | 0 | - |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 6.5B | 6.9B | 7.1B | 9.4B | 10.0B |
Key Metrics | |||||
Total Debt | 4.8B | 4.6B | 2.4B | 28.0M | 0 |
Working Capital | 1.0B | 1.2B | 841.0M | 536.0M | 745.0M |
Balance Sheet Composition
Bausch + Lomb Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -305.0M | -248.0M | 15.0M | 193.0M | -17.0M |
Depreciation & Amortization | 436.0M | 382.0M | 379.0M | 415.0M | 442.0M |
Stock-Based Compensation | 92.0M | 74.0M | 62.0M | 62.0M | 50.0M |
Working Capital Changes | -248.0M | -140.0M | -12.0M | 41.0M | -99.0M |
Operating Cash Flow | 48.0M | 110.0M | 339.0M | 825.0M | 470.0M |
Investing Activities | |||||
Capital Expenditures | -291.0M | -181.0M | -175.0M | -193.0M | -253.0M |
Acquisitions | -138.0M | -1.9B | -45.0M | -16.0M | 0 |
Investment Purchases | -12.0M | -17.0M | -17.0M | -19.0M | -6.0M |
Investment Sales | 14.0M | 16.0M | 22.0M | 14.0M | 9.0M |
Investing Cash Flow | -425.0M | -2.1B | -215.0M | -214.0M | -250.0M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 631.0M | 2.3B | 2.5B | 28.0M | 0 |
Debt Repayment | -430.0M | -161.0M | -13.0M | 0 | 0 |
Financing Cash Flow | 178.0M | 2.1B | 81.0M | -712.0M | -232.0M |
Free Cash Flow | -59.0M | -198.0M | 170.0M | 680.0M | 263.0M |
Net Change in Cash | -199.0M | 66.0M | 205.0M | -101.0M | -12.0M |
Cash Flow Trend
Bausch + Lomb Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-16.89
Forward P/E
12.77
Price to Book
0.84
Price to Sales
1.10
PEG Ratio
0.29
Profitability Ratios
Profit Margin
-5.58%
Operating Margin
0.86%
Return on Equity
-4.02%
Return on Assets
0.47%
Financial Health
Current Ratio
1.55
Debt to Equity
76.20
Beta
0.63
Per Share Data
EPS (TTM)
$-0.78
Book Value per Share
$18.20
Revenue per Share
$13.87
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
blco | 5.4B | -16.89 | 0.84 | -4.02% | -5.58% | 76.20 |
Intuitive Surgical | 163.3B | 63.00 | 9.08 | 16.04% | 28.51% | 0.00 |
Becton, Dickinson | 55.7B | 35.46 | 2.18 | 6.18% | 7.41% | 75.93 |
Avantor | 9.7B | 14.15 | 1.55 | 11.73% | 10.31% | 67.49 |
Align Technology | 9.7B | 22.33 | 2.45 | 11.41% | 11.04% | 3.14 |
AptarGroup | 8.8B | 23.01 | 3.25 | 15.26% | 10.84% | 43.12 |
Financial data is updated regularly. All figures are in the company's reporting currency.